Literature DB >> 36197646

The perception of parents with a child with sickle cell disease in Ghana towards prenatal diagnosis.

Menford Owusu Ampomah1, Karl Atkin2, Kate Flemming2,3.   

Abstract

Sickle cell disease is a global health concern. In the UK and USA, where the condition is common, prenatal testing is a routine aspect of antenatal care and offered on the basis of informed reproductive choice. Notwithstanding considerable advances in testing technologies, prenatal diagnosis for sickle cell disease is not common in Africa. There is a particular lack of research examining parental perceptions about the acceptability of antenatal screening. This qualitative paper explores the perceptions of parents, who had lived experiences of caring for a child with SCD, towards prenatal testing for sickle cell in Ghana. A purposive sample of 27 parents (four fathers and 23 mothers) was recruited via a sickle cell clinic in Accra, Ghana. Material was collected using semi-structured interview, using a topic guide that explored parental views on prenatal testing, along with factors influencing decision making about antenatal care. The findings shown that parents believed the decision to accept testing should be negotiated between both parents rather than the extended family. The decision to accept testing did not mean that parents would use the information to terminate the pregnancy of a child with SCD. They mentioned that they were more likely to use the test result to prepare themselves for the birth of their child. Parents accepted, however, that choice was important and that some parents may wish to terminate the pregnancy, given the impact of SCD on a person's quality of life. Parents lack awareness about prenatal testing because the procedure was not part of antenatal services in Ghana. However, the majority would accept testing should the process be available and affordable. The paper suggests that policy needs to establish and promote sickle cell prenatal testing/prenatal diagnosis and awareness among at-risk populations, bearing in mind the cost implication of the technology, equal access to healthcare, and the importance of informed reproductive decision making, which connects to the parents' experience of testing/screening.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Antenatal screening; Ghana; Parents; Perception; Prenatal diagnosis; Reproductive choice; Sickle cell disorders/disease

Year:  2022        PMID: 36197646     DOI: 10.1007/s12687-022-00609-9

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  20 in total

Review 1.  Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening.

Authors:  Yvonne Bombard; Fiona A Miller; Robin Z Hayeems; Denise Avard; Bartha M Knoppers
Journal:  Eur J Hum Genet       Date:  2010-03-03       Impact factor: 4.246

Review 2.  A comprehensive review of the policy and programmatic response to chronic non-communicable disease in Ghana.

Authors:  W K Bosu
Journal:  Ghana Med J       Date:  2012-06

3.  Autism spectrum disorders: a qualitative study of attitudes toward prenatal genetic testing and termination decisions of affected pregnancies.

Authors:  L S Chen; L Xu; S U Dhar; M Li; D Talwar; E Jung
Journal:  Clin Genet       Date:  2014-11-06       Impact factor: 4.438

4.  Challenges to the reproductive-health needs of African women: on religion and maternal health utilization in Ghana.

Authors:  Stephen Obeng Gyimah; Baffour K Takyi; Isaac Addai
Journal:  Soc Sci Med       Date:  2006-01-06       Impact factor: 4.634

Review 5.  Ethical considerations in prenatal diagnosis.

Authors:  E A Gates
Journal:  West J Med       Date:  1993-09

6.  Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.

Authors:  Daniel Fortuny; Judith Balmaña; Begoña Graña; Asunción Torres; Teresa Ramón y Cajal; Esther Darder; Neus Gadea; Angela Velasco; Consol López; Judit Sanz; Carmen Alonso; Joan Brunet
Journal:  Hum Reprod       Date:  2008-12-26       Impact factor: 6.918

7.  Attitudes towards prenatal diagnosis and termination of pregnancy for thalassaemia in pregnant Pakistani women in the North of England.

Authors:  Shenaz Ahmed; Josephine M Green; Jenny Hewison
Journal:  Prenat Diagn       Date:  2006-03       Impact factor: 3.050

8.  'Who's the guy in the room?' Involving fathers in antenatal care screening for sickle cell disorders.

Authors:  Karl Atkin; Maria Berghs; Simon Dyson
Journal:  Soc Sci Med       Date:  2015-01-22       Impact factor: 4.634

9.  Impact on informed choice of offering antenatal sickle cell and thalassaemia screening in primary care: a randomized trial.

Authors:  Katrina Brown; Elizabeth Dormandy; Erin Reid; Martin Gulliford; Theresa Marteau
Journal:  J Med Screen       Date:  2011       Impact factor: 2.136

10.  Experience as knowledge: Disability, distillation and (reprogenetic) decision-making.

Authors:  Felicity K Boardman
Journal:  Soc Sci Med       Date:  2017-09-08       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.